Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia

Journal of the Neurological Sciences

Volumn 153, Issue 1, 1997, Pages 76-81

  Ihara, Y ^a   Hayabara, T ^a   Sasaki, K ^b   Fujisawa, Y ^b   Kawada, R ^c   Yamamoto, T ^c   Nakashima, Y ^d   Yoshimune, S ^d   Kawai, M ^e   Kibata, M ^a   Kuroda, S ^f  

^a National Hospital Organization   (Japan)

^b Kinoko Espoir Hospital   (Japan)

^c 2 15 20 Tomi machi Okayama City   (Japan)

^d Sanyo Hospital   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

^f OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Alzheimer's disease; Free radicals; Oxidative stress; Superoxide dismutase (SOD); Vascular dementia

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; FREE RADICAL;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; MULTIINFARCT DEMENTIA; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA, VASCULAR; DISEASE PROGRESSION; FEMALE; FREE RADICALS; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; RISK FACTORS; SUPEROXIDE DISMUTASE;

EID: 0031471491     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00172-X     Document Type: Article

References (22)

1. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. American Psychiatric Association, Washington, DC.
2. Arai K., Iizuka S., Tada Y., Oikawa K., Taniguchi N. Increase in the glucosylated form of erythrocyte Cu-Zn-superoxide dismutase in diabetes and close association of the non-enzymatic glucosylation with the enzyme activity. Biochim. Biophys. Acta. 924:1987;292-296.
3. Araujo F.B., Barbosa D.S., Hsin C.Y., Maranhão R.C., Abdalla D.S.P. Evaluation of oxidative stress in patients with hyperlipidemia. Atherosclerosis. 117:1995;61-71.
4. Bowling A.C., Beal M.F. Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci. 56:1995;1151-1171.
5. Chen L., Richardson J.S., Caldwell J.E., Ang L.C. Regional brain activity of free radical defense enzyme in autopsy samples from patients with Alzheimer's disease and from nondemented controls. Int. J. Neurosci. 75:1994;83-90.
6. de Lustig E.S., Serra J.A., Kohan S., Canziani G.A., Famulari A.L., Dominguez R.O. Copper-zinc superoxide dismutase activity in red blood cells and serum in demented patients and in aging. J. Neurol. Sci. 115:1993;18-25.
7. Hayakawa M., Hattori K., Sugiyama S., Ozawa T. Age-associated oxygen damage and mutations in mitochondrial DNA in human hearts. Biochem. Biophys. Res. Commun. 189:1992;979-985.
8. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. A new clinical scale for the staging of dementia. Br. J. Psychiatry. 140:1982;566-572.
9. Ihara Y., Hayabara T., Namba R., Nobukuni K., Mori A. Free radical, lipid peroxide and antioxidant in mitochondrial encephalomyopathy. Rinsho Sinkeigaku. 34:1994;593-595.
10. Ito H., Torii M., Suzuki T. Decreased superoxide dismutase activity and increased superoxide anion production in cardiac hypertrophy of spontaneously hypertensive rats. Clin. Exp. Hypertens. 17:1995;803-816.
11. Lovell M.A., Ehmann W.D., Butler S.M., Markesbery W.R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. 45:1995;1594-1601.
12. Marklund S.L. Distribution of Cu,Zn superoxide dismutase and Mn superoxide dismutase in human tissues and extracellular fluid. Acta Physiol. Scand. 492:1980;19-23.
13. McCord J.M. Free radicals and myocardial ischemia: overview and outlook. Free Rad. Biol. Med. 4:1988;9-14.
14. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology. 34:1984;939-944.
15. Mecocci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36:1994;747-751.
16. Meyer J.S., McClintic K.L., Rogers R.L., Sims P., Mortel K.F. Aetiological considerations and risk factors for multi-infarct dementia. J. Neurol. Neurosurg. Psychiatry. 51:1988;1489-1497.
17. Mutisya E.M., Bowling A.C., Beal M.F. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 63:1994;2179-2184.
18. Parker W.D., Mahr N.J., Filley C.M., Parks J.K., Hughes D., Young D.A., Cullum C.M. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology. 44:1994;1086-1090.
19. Perrin R., Briançon S., Jeandel C., Artur Y., Minn A., Penin F., Siest G. Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer's disease: a case-control study. Gerontology. 36:1990;306-313.
20. Richardson J.S. Free radicals in the genesis of Alzheimer's disease. Ann. NY Acad. Sci. 695:1993;73-76.
21. Siesjo B.K. Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. J. Neurosurg. 77:1992;337-354.
22. Simonian N.A., Hyman B.T. Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation. J. Neuropathol. Exp. Neurol. 53:1994;508-512.